Fatty Liver News and Research

Latest Fatty Liver News and Research

In mice, drug protects against diabetes and atherosclerosis

Blocking a single protein with an experimental drug prevented and treated both type 2 diabetes and atherosclerosis in laboratory mice that had been fed unhealthy diets and were genetically predisposed to these common killers, according to an article published online in Nature.

8 Jun 2007

FASgen announces new diagnostic test for steatohepititis

FASgen Inc. announced it has successfully expanded the potential use for its serum FAS (fatty acid synthase) ELISA diagnostic research test, FAS-Detect ELISA for the identification of Non-Alcoholic Steatophepititis (NASH).

1 Jun 2007

People may need more dietary choline than previously thought

A new study published in the May issue of the American Journal of Clinical Nutrition indicates that the current recommended Adequate Intake (AI) for choline may, in fact, be inadequate for some people.

28 May 2007

High-fat and sugar-sweetened diet compounded by a sedentary lifestyle will have severe health repercussions

It's research that may have you thinking twice before upgrading to the large size at your favorite fast food joint.

24 May 2007

Nutrient "floodgate" protects against inflammatory immune response

After every meal, the body must prevent the immune system from launching an all-out fight against food.

4 May 2007

Geisinger Health System launches study on obesity and related liver problem

Relying on one of the largest collections of liver tissue samples ever acquired by a single organization, Geisinger Health System researchers have embarked on a massive study of one of the fastest growing liver problems.

17 Apr 2007

NAFLD fibrosis score helps predict advanced fibrosis in patients with nonalcoholic fatty liver disease

Certain routine demographic, clinical, and laboratory values can be used to identify advanced fibrosis in patients with nonalcoholic fatty liver disease (NAFLD).

4 Apr 2007

Voluntary living liver donors should undergo a careful, but quick, workup

...and their desire for altruism should not be hampered by negativism from the transplant community, say the authors of a new study in the April issue of Liver Transplantation, the official journal of the American Association for the Study of Liver Diseases (AASLD) and the International Liver Transplantation Society (ILTS).

4 Apr 2007

Growing number of young people have fatty liver disease

Indiana University School of Medicine researchers are taking a closer look at a disease whose incidence is rising as obesity in children increases.

15 Mar 2007

Weight loss supplement - conjugated linoleic acid - shows nasty side effects

A supplement some people turn to in hopes of losing a few pounds may have some previously unknown, unsavory side effects, suggest two new studies.

30 Jan 2007

Molecular switch that regulates fat and cholesterol production identified

Researchers at Harvard Medical School and Massachusetts General Hospital have identified how a molecular switch regulates fat and cholesterol production

2 Aug 2006

Impact of obesity on treatment of chronic hepatitis C

According to a new study, obese patients chronically infected with the hepatitis C virus (HCV) and treated with combination drug therapy may have better outcomes if the underlying abnormalities caused by excessive fat tissue are corrected.

6 Jun 2006

New study may advance treatments to prevent type 2 diabetes and metabolic syndrome

Insulin uses two distinct mechanisms to control glucose and the metabolism of blood fats (lipids) in the liver, a new Joslin Diabetes Center-led study has discovered.

23 May 2006

The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis

An imbalance in the lipid content of the liver appears to trigger the downward spiral that leads some with fatty liver disease to advance to full-blown liver failure, according to a new study in the May Cell Metabolism.

11 May 2006

Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the U.S.

A new study on the relationship between nonalcoholic fatty liver disease (NAFLD) and heart disease found that patients with an elevated level of the enzyme associated with NAFLD had an increased risk of coronary heart disease, which appears to be related to insulin resistance, obesity and central fat distribution.

3 May 2006

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases

Patients and their physicians should be careful when selecting a chemotherapy drug to treat colorectal cancer that has spread to the liver, say researchers at The University of Texas M. D. Anderson Cancer Center in Houston.

3 May 2006

Drinking lots of coffee and tea can reduce the risk of chronic liver disease

A study published in the American Gastroenterological Association (AGA) journal Gastroenterology found that people at high risk for liver injury may be able to reduce their risk for developing chronic liver disease significantly by drinking more than two cups of coffee or tea daily.

2 Dec 2005

Accumulation of fat in the liver linked to hypertension

The accumulation of fat in the liver, or "fatty liver," resulting from accumulation of central body fat, and perhaps not alcohol consumption, may represent an important underlying mechanism for the association between liver enzymes and hypertension.

3 Nov 2005

Study shows that high-fat diets correlate to a chronic inflammatory state in the liver,

Mice that were fed diets high in fat and sugar developed immune system abnormalities in their livers, including reduced numbers of natural killer T (NKT) cells. These diet-related changes may contribute to obesity-related liver disease, according to a new study.

3 Oct 2005

Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in children

The Nonalcoholic Steatohepatitis (NASH) Clinical Research Network has launched its second clinical trial to study NASH, a liver disease that resembles alcoholic liver disease but occurs in patients who drink little or no alcohol. The first trial, launched in January of this year, focuses on adults, while the second trial studies the disease in children.

27 Sep 2005

Fatty Liver News and Research

Latest Fatty Liver News and Research

In mice, drug protects against diabetes and atherosclerosis

FASgen announces new diagnostic test for steatohepititis

People may need more dietary choline than previously thought

High-fat and sugar-sweetened diet compounded by a sedentary lifestyle will have severe health repercussions

Nutrient "floodgate" protects against inflammatory immune response

Geisinger Health System launches study on obesity and related liver problem

NAFLD fibrosis score helps predict advanced fibrosis in patients with nonalcoholic fatty liver disease

Voluntary living liver donors should undergo a careful, but quick, workup

Growing number of young people have fatty liver disease

Weight loss supplement - conjugated linoleic acid - shows nasty side effects

Molecular switch that regulates fat and cholesterol production identified

Impact of obesity on treatment of chronic hepatitis C

New study may advance treatments to prevent type 2 diabetes and metabolic syndrome

The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis

Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the U.S.

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases

Drinking lots of coffee and tea can reduce the risk of chronic liver disease

Accumulation of fat in the liver linked to hypertension

Study shows that high-fat diets correlate to a chronic inflammatory state in the liver,

Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in children

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Fatty Liver News and Research

Latest Fatty Liver News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in